ArticleEuropean endocrinology2014

The Future of Combination Therapies of Insulin with a Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes - Is it Advantageous?

Baptist GallwitzPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.